NCT06362902

Brief Summary

The purpose of this study is to investigate the preliminary surgical outcomes of laparoscopic right hemicolectomy with transrectal specimen extraction. The hypothesis is that this type of natural orifice specimen extraction surgery (NOSES) could achieve good short-term and oncological outcomes for right colon cancer patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 8, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 12, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

April 12, 2024

Status Verified

April 1, 2024

Enrollment Period

1.5 years

First QC Date

April 8, 2024

Last Update Submit

April 8, 2024

Conditions

Keywords

Colon cancerLaparoscopic Right HemicolectomyNatural orifice specimen extraction surgery

Outcome Measures

Primary Outcomes (1)

  • The rate of postoperative complications

    The rate of postoperative complications = patients with any postoperative complications/all cases.

    up to 30 days

Secondary Outcomes (4)

  • Operating time

    up to 1 days

  • Estimated blood loss

    up to 1 days

  • The time of first flatus

    up to 5 days

  • Postoperative hospitalization

    up to 30 days

Study Arms (1)

Laparoscopic Right Hemicolectomy With Transrectal Specimen Extraction

EXPERIMENTAL

STEP 1: Dissection and separation The mesentery and vessels were dissected and separated according to the principle of complete mesocolic excision. STEP 2: Intracorporeal anastomosis An enterotomy was performed on the antimesenteric side of the ileum at the edge of the staple line. This maneuver was replicated on the transverse colic side. Subsequently, the cartridge jaw of the stapler was inserted into the transverse colon. The stapler was fired and withdrawn, and the common enterotomy was sealed by using another linear stapler. STEP 3: Transrectal specimen extraction A longitudinal incision was made on the anterior of wall of the upper rectum. The assistant employed oval forceps to extract the specimen along with the protective sleeve through the incision in the upper rectum. After the complete extraction of the specimen, a full-layer running suturing was performed to close the incision.

Procedure: Laparoscopic right hemicolectomy with transrectal specimen extraction

Interventions

Laparoscopic right hemicolectomy with transrectal specimen extraction

Laparoscopic Right Hemicolectomy With Transrectal Specimen Extraction

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Biopsy proven colon carcinoma;
  • Imaging diagnosis of T1-3 colon cancer;
  • The tumor located in the cecum, ascending colon, or colonic hepatic flexure;
  • Maximal tumor diameter ≤5 cm;
  • Body mass index (BMI) ≤30 kg/m2;
  • Written informed consent;

You may not qualify if:

  • Complete intestinal obstruction;
  • Hepatitis activity and peripheral neuropathy (such as peripheral neuritis, pseudo meningitis, motor neuritis, and sensory impairment);
  • Significant organ dysfunction or other significant diseases, including clinically relevant coronary artery disease, cardiovascular disease, or myocardial infarction within the 12 months before enrollment; severe neurological or psychiatric history; severe infection; active disseminated intravascular coagulation;
  • Pregnancy or breastfeeding;
  • Alcohol abuse or drug addiction;
  • Concurrent uncontrolled medical condition;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cancer Center

Beijing, Beijing Municipality, 100000, China

RECRUITING

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • Haitao Zhou, M.D.

    National Cancer Center, China

    STUDY CHAIR

Central Study Contacts

Zheng Xu, M.D.

CONTACT

Yueyang Zhang, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

April 8, 2024

First Posted

April 12, 2024

Study Start

March 1, 2024

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

April 12, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Participants' data are only allowed to be used for the analysis of this study and are not authorized to be shared with other researchers.

Locations